Jump to contentU of M Health System Logo
Consult Request Guidelines
for University of Michigan Addiction Treatment Services (UMATS)
UMHS HOME


Search UMHS Site
   |   For a Physician-to-Physician Consultation Contact  M-LINE: 734-936-3856    HOME | CONDITION LIST


SEARCH FOR CONSULT REQUEST
GUIDELINES

Services for Physicians
Appointments and Admission
Arranging Transport
Educational Resources
Physician and Clinic Directory

  


CONSULT REQUEST GUIDELINES
University of Michigan Addiction Treatment Services (UMATS)
Suggested Pre-Referral Evaluation and Management Guidelines

Alcohol and other drug use is prevalent among patients in many clinical settings, contributing to increased risk for injury and illness, reduced adherence to medical and psychiatric treatments, and untoward patient outcomes. Periodic screening and assessment for substance use is consistent with the delivery of good medical care.

Many patients can eliminate or reduce their substance use in response to supportive prompts from a health care provider. It has been recommended that all health care professionals know how to provide Brief Interventions to their patients. A number of helpful pamphlets and brochures are available from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) http://www.niaaa.nih.gov/ and the National Institute on Drug Abuse (NIDA) http://www.nida.nih.gov/

If you suspect that substance use may be a problem, then avoid prescribing potentially addictive substances, such as benzodiazepines (e.g., Ativan, Valium, or Xanax) or opioids (e.g., codeine, Vicodin, or OxyContin).

Suggested Additional Test/Management Prior to Specialty Visit

Some patients may require additional assistance. Consider recommending a trial abstinence period, or mutual-help group attendance, such as SMART Recovery, Women for Sobriety, Alcoholics Anonymous (AA), or Narcotics Anonymous (NA).

Lab tests may include blood work for liver function tests, including ALT, AST, and GGTP for alcohol, and urine drug screens for other substances.

Medications, such as disulfiram (Antabuse), naltrexone (ReVia, Vivitrol), or buprenorphine (Suboxone) may be helpful, but are most effective when administered in conjunction with a therapy component, or specialized addictions treatment.

Patient Education/Information (includes preps) UMATS: http://www.umats.org
NIAAA: http://www.niaaa.nih.gov/
NIDA: http://www.nida.nih.gov/
SMART Recovery: http://www.smartrecovery.org/
Alcoholics Anonymous: http://www.aa.org/
Appointment Timeframe Most patients are seen within 5 clinic days or less.
How to Get Results to Consultant  
Clinic Contact Information UMHS patients:
  1. Complete the consult request form and image into CareWeb.
  2. Direct the patient to call Psychiatry Intake & Call Center at 734-764-0231 or 1-800-525-5188 to make an appointment.
UMATS general information: (734) 232-0600
Clinic Location Sites Ambulatory Psychiatry at the Rachel Upjohn Building
UM Consulting Physician UMATS Faculty and Staff
Revised on: 06/23/2009
 
 

© 2013 University of Michigan Health System
If you have any questions about this web site, please contact us

The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer
and Privacy Statement.